Gabriella A. Aitcheson

Targeting FGFR in intrahepatic cholangiocarcinoma [iCCA]: leading the way for precision medicine in biliary tract cancer [BTC]?

A. Mahipal, B. John, Gabriella A. Aitcheson, 2021, Expert opinion on investigational drugs.

Update on the Evaluation and Management of Portal Hypertension.

B. John, I. John, Gabriella A. Aitcheson, 2021, Gastroenterology & hepatology.

The Impact of Racial Disparities on Liver Disease Access and Outcomes

L. Nephew, Gabriella A. Aitcheson, M. Iyengar, 2022, Current Treatment Options in Gastroenterology.

Case of anti-Zic4 antibody-mediated cerebellar toxicity induced by dual checkpoint inhibition in head and neck squamous cell carcinoma

C. Perez, N. Khakoo, Gabriella A. Aitcheson, 2020, BMJ Case Reports.